Phase 3 enrollment of 417 patients for the landmark MODEL trial of a novel peptide intradiscal injection for low back pain is now completed.
Biologics Premium
Phase 3 Enrollment Done for 1st Intradiscal Back Pain Injection
1 min read Premium comments

Premium#degenerativediscdisease#phase3modeltrial#spinebiopharma
React:
